Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901
Thomas Shea, Jeffrey Johnson, Peter Westervelt, Sherif Farag, John McCarty, Asad Bashey, Luis Isola, Lee Anne Baxter-Lowe, Michael Kelly, Kouros Owzar, Charles Linker
Dive into the research topics of 'Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901'. Together they form a unique fingerprint.